Trial intelligence / Profile preview

Desflurane vs TIVA TCI ELEVELD Model for Bariatric Surgery

NCT07568938Recruiting

Sponsor
G. Gennimatas General Hospital
Start
Jan 2024
Primary completion
Feb 2027
Modality
Allosteric Modulators
Countries
1
01

Overview

Randomised trial of desflurane in obesity (2 arms), sponsored by G. Gennimatas General Hospital. Primary endpoints: Perioperative trend of Cortisol, Perioperative trend of Adrenaline and 5 more. Started Jan 2024; status: recruiting.

02

Drugs

desflurane
03

Conditions

obesity

Beyond the preview

Go deeper on NCT07568938.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07568938.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call